Back

ESMO 2023 - European Society of Medical Oncology Congress

Oct 20 - Oct 24, 2023 | MadridSpain

LARVOL is not affiliated with European Society of Medical Oncology Congress and all trademarks, logos, and brand names are property of their respective owners

Showing 11 titles linked to Trials

Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Final Results of RADICALS RT Randomised Controlled Trial [NCT00541047]

  • Proffered Paper

ARTO (NCT03449719), randomized phase II trial testing stereotactic body radiotherapy and Abiraterone Acetate in Oligometastatic castrate-resistant prostate cancer patients

  • Oral

Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC) – The AVETUXIRI Phase II study (NCT03608046).

  • E-Poster

Phase 1b/2 Open-label Study (NCT04073615) to Evaluate the Safety, Tolerability, and Efficacy of Rivoceranib plus Trifluridine/Tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer

  • E-Poster

Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial

  • E-Poster

Tumor-restricted delivery of an immune-therapeutic payload by modified macrophages for the treatment of Glioblastoma: the TEM-GBM STUDY (NCT03866109)

  • E-Poster

Final top-line results of the BGBC008 phase 2, multicenter study of bemcentinib and pembrolizumab (bem+pembro) in 2nd line (2L) advanced non-squamous (NS) non-small cell lung cancer (NSCLC) (NCT03184571)

  • E-Poster

Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant Non-Small Cell Lung Cancer (NSCLC) according to TP53 mutational status (TEMPLE-2/NCT05785208).

  • E-Poster

Blood-borne Assessment of Stromal activation in esophageAL adenocarcinoma to guide tocilizumab Therapy: a randomized phase II proof-of-concept study (NCT04554771)

  • E-Poster

PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914)

  • E-Poster

Results from a Phase I/II trial of tinostamustine monotherapy in advanced solid tumours (NCT03345485): safety and efficacy in a subset of patients (pts) with soft tissue sarcoma (STS)

  • E-Poster